BAX and ovarian carcinoma: We have shown previously that the combination of thioxodihydroquinazolinone analogs with cisplatin induces severe mitochondrial uncoupling and Bax/Bak-independent mitochondrial apoptosis in cisplatin-resistant ovarian cancer cells [17, 18].